Chagas disease vaccine - ConserV Bioscience
Latest Information Update: 30 Mar 2021
At a glance
- Originator ConserV Bioscience
- Class Protozoan vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Chagas disease
Most Recent Events
- 30 Mar 2021 ConserV Bioscience patent protection for its vaccine in World (ConserV Bioscience pipeline, March 2021).
- 30 Mar 2021 ConserV Bioscience patents pending for its vaccine in World (ConserV Bioscience pipeline, March 2021).
- 01 Jan 2021 Preclinical trials in Chagas disease in United Kingdom (Parenteral) before January 2021 (ConserV Bioscience pipeline, January 2021)